European Patent Office

T 0251/25 of 29.06.2026

European Case Law Identifier
ECLI:EP:BA:2026:T025125.20260629
Date of decision
29 June 2026
Case number
T 0251/25
Online on
29 September 2026
Petition for review of
-
Application number
14715274.8
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Therapeutic uses of empagliflozin
Applicant name
Boehringer Ingelheim International GmbH
Opponent name
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
SANDOZ AG
Zentiva k.s.
STADA Arzneimittel AG
Sanovel IIaç San. ve Tic. A.S
Adalvo Ltd.
Aera A/S
HGF Limited
Generics (U.K.) Limited
Dr Reddy's Laboratories (UK) Limited
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 83
Keywords
Sufficiency of disclosure - (no)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.